Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rapid Intravenous Infusion of 10 and 22 Degrees Celsius Ringer's Lactate in Healthy Volunteers and Its Effects on Circulation and Hemostasis - a Randomized Crossover Trial

NCT06622499 is registered in ClinicalTrials.gov with Esbjerg Hospital - University Hospital of Southern Denmark as lead sponsor.

NCT NCT06622499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06622499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rapid Intravenous Infusion of 10 and 22 Degrees Celsius Ringer's Lactate in Healthy Volunteers and Its Effects on Circulation and Hemostasis - a Randomized Crossover Trial
Lead sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Phase
Phase 1
Overall status
Completed
Start date
November 6, 2023
Completion date
December 20, 2023
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodynamic instability